DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chemistry

• Publication date

  2012-10-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/chem.201202050PMID 22987397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells.

  2012cited by this paper
• Next-generation anticancer metallodrugs.

  2012cited by this paper
• Molecular mechanisms of cisplatin resistance

  2012cited by this paper
• Unusual Reactivity of a Potent Platinum-Acridine Hybrid Antitumor Agent.

  2011cited by this paper
• Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.

  2011cited by this paper
• Inhibition of DNA Synthesis by a Platinum-Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung Cancer.

  2011cited by this paper
• Inhibition of DNA Synthesis by a Platinum–Acridine Hybrid Agent Leads to Potent Cell Kill in Nonsmall Cell Lung Cancer

  2011cited by this paper
• A Tetrazolato‐Bridged Dinuclear Platinum(II) Complex Exhibits Markedly High in vivo Antitumor Activity against Pancreatic Cancer

  2011cited by this paper
• Metal complexes as DNA intercalators.

  2011cited by this paper
• Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells

  2011cited by this paper
• Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay

  2011cited by this paper
• Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.

  2011cited by this paper
• Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

  2011cited by this paper
• The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.

  2010cited by this paper
• The status of platinum anticancer drugs in the clinic and in clinical trials.

  2010cited by this paper
• Targeted therapies for non-small cell lung cancer.

  2010cited by this paper
• Antibody-drug conjugates: targeted drug delivery for cancer.

  2010cited by this paper
• Transcription inhibition by platinum-DNA cross-links in live mammalian cells.

  2010cited by this paper
• Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.

  2010cited by this paper
• Characteristic effect of an anticancer dinuclear platinum(II) complex on the higher-order structure of DNA

  2010cited by this paper
• KRAS mutations in non-small cell lung cancer.

  2009cited by this paper
• Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

  2009cited by this paper
• Unusual DNA binding modes for metal anticancer complexes.

  2009cited by this paper
• ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer.

  2008cited by this paper
• cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

  2008cited by this paper
• Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.

  2008cited by this paper
• A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.

  2008cited by this paper
• Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

  2007cited by this paper
• Trans-platinum complexes in cancer therapy.

  2007cited by this paper
• Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

  2007cited by this paper
• Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis.

  2007cited by this paper
• Biochemical mechanisms of cisplatin cytotoxicity.

  2007cited by this paper
• Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.

  2007cited by this paper
• Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.

  2007cited by this paper
• Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.

  2006cited by this paper
• A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding.

  2006cited by this paper
• A third mode of DNA binding: Phosphate clamps by a polynuclear platinum complex.

  2006cited by this paper
• Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake.

  2006cited by this paper
• Biological Consequences of Trinuclear Platinum Complexes: Comparison of [{trans-PtCl(NH3)2}2μ-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with Its Noncovalent Congeners

  2006cited by this paper
• Duplex-promoted platination of adenine-N3 in the minor groove of DNA: challenging a longstanding bioinorganic paradigm.

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin

  2005cited by this paper
• A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.

  2005cited by this paper
• Novel approaches towards development of non-classical platinum-based antineoplastic agents: design of platinum complexes characterized by an alternative DNA-binding pattern and/or tumor-targeted cytotoxicity.

  2005cited by this paper
• Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.

  2005cited by this paper
• Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity

  2005cited by this paper
• Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.

  2004cited by this paper
• Biophysical characterization and molecular modeling of the coordinative-intercalative DNA monoadduct of a platinum-acridinylthiourea agent in a site-specifically modified dodecamer

  2004cited by this paper
• Polynuclear platinum drugs.

  2004cited by this paper
• Structure–activity relationships in platinum–acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity

  2004cited by this paper
• Protein interactions with platinum-DNA adducts: from structure to function.

  2004cited by this paper
• Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.

  2004cited by this paper
• Platinum-based chemotherapy in metastatic breast cancer: current status.

  2004cited by this paper
• Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent.

  2004cited by this paper
• Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation.

  2004cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates.

  2002cited by this paper
• Is cisplatin-induced cell death always produced by apoptosis?

  2001cited by this paper
• Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.

  2001cited by this paper
• Kinetic Studies of the TATA-binding Protein Interaction with Cisplatin-modified DNA* 210

  2001cited by this paper
• HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.

  2000cited by this paper
• DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.

  2000cited by this paper
• Structural Characterization of the Human Interleukin-13 Receptor α1 Gene Promoter☆☆☆

  1999cited by this paper
• Structural characterization of the human interleukin-13 receptor alpha1 gene promoter.

  1999cited by this paper
• Palliative chemotherapy: no longer a contradiction in terms.

  1999cited by this paper
• Testicular cancer: an oncological success story.

  1997cited by this paper
• Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.

  1996cited by this paper
• Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry.

  1996cited by this paper
• Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.

  1996cited by this paper
• Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.

  1993cited by this paper
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

  1992cited by this paper
• Unwinding of supercoiled DNA by platinum-ethidium and related complexes

  1992cited by this paper
• Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.

  1989cited by this paper
• Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks.

  1988cited by this paper
• The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.

  1987cited by this paper
• Cis effect of dimethyl sulfide and the leaving group effect in reactions of the cationic complex chloro(dimethyl sulfide)(1,2-diaminoethane)platinum(II) chloride

  1981cited by this paper
• Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexes

  1973cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper

• Short-Chain and Long-Chain Fatty Acid-Containing Platinum-Acridine Anticancer Prodrugs: Exploiting Alternative Mechanisms of Cellular Internalization.

  2026cites this paper
• Mitochondria-Targeted Benzoxazole-Based Platinum Photosensitizer Complexes: Photophysical Properties and Photocytotoxicity Evaluation Against Breast and Gastric Cancer Cells.

  2025cites this paper
• Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy

  2024cites this paper
• A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity.

  2024cites this paper
• Platinum-Acridine Agents with High Activity in Cancers Expressing the Solute Carrier MATE1 (SLC47A1).

  2023cites this paper
• CX-5461-inspired monofunctional platinum RNA polymerase I selective inhibitors with selective lethality in BRCA1-deficient cancer cells

  2023cites this paper
• Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.

  2023cites this paper
• DNA, a target of mixed chelate copper(II) compounds (Casiopeinas®) studied by electrophoresis, UV-vis and circular dichroism techniques.

  2022cites this paper
• Chemosensitivity‐Gene Expression Correlations and Functional Enrichment Analysis Provide Insight into the Mechanism of Action of a Platinum‐Acridine Anticancer Agent

  2022cites this paper
• Metallodrugs: an approach against invasion and metastasis in cancer treatment

  2022cites this paper
• Investigation on Optical and Biological Properties of 2‐(4‐Dimethylaminophenyl)benzothiazole Based Cycloplatinated Complexes

  2021cites this paper
• Novel Cytotoxic Phenanthro-triazine-3-thiol Derivatives as Potential DNA Intercalators and Bcl-2 Inhibitors

  2021cites this paper
• Luminescent cyclometalated platinum(II) complexes with acyclic diaminocarbene ligands: structural, photophysical and biological properties.

  2021cites this paper
• Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.

  2021cites this paper
• Fluorinated Cycloplatinated(II) Complexes Bearing Bisphosphine Ligands as Potent Anticancer Agents.

  2020cites this paper
• Evaluation of a Platinum–Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma

  2020cites this paper
• A membrane transporter determines the spectrum of activity of a potent platinum–acridine hybrid anticancer agent

  2020cites this paper
• Exploiting azide–alkyne click chemistry in the synthesis, tracking and targeting of platinum anticancer complexes

  2020cites this paper
• Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.

  2020cites this paper
• A Membrane Transporter Determines the Spectrum of Activity of a Potent DNA-Targeted Hybrid Anticancer Agent

  2020cites this paper
• Cytotoxicity and DNA interaction in a series of aryl terminated iminopyridine Pt(II) complexes.

  2020cites this paper
• Effect of the nonleaving groups on the cellular uptake and cytotoxicity of platinum-acridine anticancer agents

  2019cites this paper
• Luminescent Cycloplatinated Complexes with Biologically Relevant Phosphine Ligands: Optical and Cytotoxic Properties.

  2019cites this paper
• pH and thermo dual stimulus‐responsive liposome nanoparticles for targeted delivery of platinum‐acridine hybrid agent

  2019cites this paper
• Photocytotoxic Activity of Copper(II) and Zinc(II) Complexes of Curcumin and (Acridinyl)dipyridophenazine

  2019cites this paper
• Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.

  2018cites this paper
• Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.

  2018cites this paper
• Synthesis, structure, and biological evaluation of a platinum‐carbazole conjugate

  2018cites this paper
• Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone.

  2018cites this paper
• Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.

  2017cites this paper
• Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation.

  2017cites this paper
• Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.

  2017cites this paper
• Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.

  2017cites this paper
• A New Approach to Sensitize Antitumor Monofunctional Platinum(II) Complexes via Short Time Photo-Irradiation.

  2017cites this paper
• New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry.

  2017cites this paper
• Platinum Intercalators of DNA as Anticancer Agents

  2017cites this paper
• 7 – Anticancer Hybrids

  2017cites this paper
• Enhanced anti-cancer efficacy to cancer cells by a novel monofunctional mononuclear platinum(II) complex containing a mixed S,N,S-donor ligand

  2017cites this paper
• Metal‐Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics

  2017cites this paper
• Study of the Ribosomal Stress Pathway in Pluripotency, Cancer and Disease

  2016cites this paper
• Correction: Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

  2016cites this paper
• Labile Pd-sulphur and Pt-sulphur bonds in organometallic palladium and platinum complexes [(COD)M(alkyl)(S-ligand)]n+-A speciation study.

  2016cites this paper
• An overview of molecular hybrids in drug discovery

  2016influential citation
• Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell Detection.

  2016cites this paper
• Synthesis and antiproliferative activity of ionic platinum(II) triphenylphosphino complexes

  2016cites this paper
• Platinum-based drugs: past, present and future

  2016cites this paper
• Design, Synthesis, and Biological Features of Platinum(II) Complexes with Rigid Steric Hindrance.

  2016cites this paper
• Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.

  2016cites this paper
• A survey of the mechanisms of action of anticancer transition metal complexes.

  2016cites this paper
• Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

  2016cites this paper
• PMS2 expression in epithelial ovarian cancer is posttranslationally regulated by Akt and essential for platinum-induced apoptosis

  2016cites this paper
• Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA Adducts.

  2015cites this paper
• Target-selective delivery and activation of platinum-based anticancer agents.

  2015cites this paper
• Luminescent pentafluorophenyl-cycloplatinated complexes: synthesis, characterization, photophysics, cytotoxicity and cellular imaging.

  2015cites this paper
• Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.

  2015cites this paper
• Biomimetic one-pot route to acridine epoxides.

  2015cites this paper
• Fine control on the photochemical and photobiological properties of Ru(II) arene complexes.

  2015cites this paper
• Platinum‐Based Anticancer Agents

  2014cites this paper
• Exploring the Scope of [Pt2(4-FC6H4)4(μ-SEt2)2] as a Precursor for New Organometallic Platinum(II) and Platinum(IV) Antitumor Agents

  2014cites this paper
• Cytotoxicity and NMR Studies of Platinum Complexes with Cyclooctadiene Ligands

  2014cites this paper
• Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.

  2014cites this paper
• Design of enzymatically cleavable prodrugs of a potent platinum-containing anticancer agent.

  2014cites this paper
• Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.

  2014cites this paper
• Acridine and its derivatives: a patent review (2009 – 2013)

  2014cites this paper
• Luminescent cyclometalated platinum(II) complex forms emissive intercalating adducts with double-stranded DNA and RNA: differential emissions and anticancer activities.

  2014cites this paper
• Investigating the cellular fate of a DNA-targeted platinum-based anticancer agent by orthogonal double-click chemistry

  2014cites this paper
• The potential of acridine carboxamide Pt complexes as anti-cancer agents : a review.

  2014cites this paper
• Uses of Metal Compounds in Medicine

  2013cites this paper
• Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents.

  2013cites this paper
• DNA Metalating—Intercalating Hybrid Agents for the Treatment of Chemoresistant Cancers

  2013cites this paper
• The Cell’s Nucleolus: an Emerging Target for Chemotherapeutic Intervention

  2013cites this paper
• Strong Cytotoxicity of Organometallic Platinum Complexes with Alkynyl Ligands

  2013cites this paper
• Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.

  2013cites this paper
• Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.

  2013cites this paper
• Synthetic methods for the preparation of platinum anticancer complexes.

  2013cites this paper